Berger Dietmarinsider trades
In SEC Form 4 filings, Berger Dietmar is listed as Chief Medical Officer of Gilead Sciences, Inc. (GILD). Berger Dietmar reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 11.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| GILDGilead Sciences, Inc. | Chief Medical Officer | 3 | Sep 11 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-11
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc. | Sep 10 | Sep 11 | M | 533 | not reported | not reported | 19,785 | No | Form 4 |
| GILDGilead Sciences, Inc. | Sep 10 | Sep 11 | F | 263 | $144.81 | $38,085 | 19,522 | No | Form 4 |
| GILDGilead Sciences, Inc. | Sep 10 | Sep 11 | M · derivative | 533 | not reported | not reported | 46,395 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.